Cerebrospinal beta-amyloid (1–42) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline

References

Page 1

	Year	Citations
Clinical diagnosis of Alzheimer's disease Guy M. McKhann, David A. Drachman, Marshall Folstein, Neurology	1984	27.8K
Vascular dementia Gustavo C. Román, T. K. Tatemichi, Timo Erkinjuntti, Neurology Cerebrovascular DiseaseNeurovascular DiseaseStroke RehabilitationAlzheimer's DiseaseStroke	1993	4.9K
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. D. E. Schmechel, Ann M. Saunders, Warren J. Strittmatter, Proceedings of the National Academy of Sciences Neurochemical BiomarkersAlzheimer's DiseaseProtein MisfoldingNeurologyLate-onset Alzheimer Disease	1993	1.5K
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions G. William Rebeck, Joell S. Reiter, Dudley K. Strickland, Neuron Receptor InteractionsAlzheimer's DiseaseApolipoprotein ESporadic AlzheimerDementia	1993	1.1K
Improved discrimination of AD patients using β-amyloid <sub>(1-42)</sub> and tau levels in CSF Frank Hulstaert, Kaj Blennow, Adrian Ivanoiu, Neurology	1999	726
Reduction of β‐amyloid peptide<sub>42</sub> in the cerebrospinal fluid of patients with Alzheimer's disease Ruth Motter, Carmen Vigo‐Pelfrey, Dora Kholodenko, Annals of Neurology Apoe GenotypeNeurochemical BiomarkersCsf Aβ 42Social SciencesAlzheimer's Disease	1995	692
Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease Niels Andreasen, Camilla Hesse, Pia Davidsson, Archives of Neurology	1999	658
High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype Douglas Galasko, L. Chang, Ruth Motter, Archives of Neurology	1998	445
Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment Nancy C. Andreasen, Lennart Minthon, Eugeen Vanmechelen, Neuroscience Letters Neurodegenerative DiseasesCerebrospinal Fluid TauAlzheimer's DiseaseBrain DevelopmentNeurochemical Biomarkers	1999	241
Cerebrospinal fluid A?42 is increased early in sporadic Alzheimer's disease and declines with disease progression Malene Jensen, Johannes Schr�der, Mari Blomberg, Annals of Neurology	1999	218

Page 1